Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients

Figure 2 Genes expressed differentially between livers with F1-2 and F3-4 fibrosis. The red and blue colors indicate relative extent of gene overexpression and underexpression, respectively, with darker colors indicating larger differences. GPCR, G protein-coupled receptor; HCC, hepatocellular carcinoma; B2M, beta-2-microglobulin; GRP25, G protein-coupled receptor 25; ADH1C, alcohol dehydrogenase 1C; AKR1D1, aldo-keto reductase 1D1; CYP2C8, cytochrome P450 2C8; ALB, albumin; FABP1, fatty acid binding protein 1; APO, apolipoprotein; NEO, neogenin homolog; ADMR, adrenomedullin receptor; GNG5, guanine nucleotide binding protein (G protein) gamma 5; ARL7, ADP-ribosylation factor-like 7; ARHGAP6, Rho GTPase activating protein 6; STK, serine/threonine kinase; GAA, glucosidase alpha acid; NR5A2, nuclear receptor subfamily 5A2; PGR, progesterone receptor; PRS2, protease serine 2; ACCN2, amiloride-sensitive cation channel 2; HOXC6, homeo box C6.